In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also ...

There is no cure for vitiligo, but there are a variety of innovative treatments that your doctor may prescribe once you've been diagnosed. It's a really exciting time to be treating vitiligo ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...

Clinical stage therapeutics startup Ahammune Biosciences, bread brand The Health Factory, proptech startup Flent and ...